Related Experiment Videos
Toxicoproteomics -- a new preclinical tool.
Lasantha R Bandara1, Sandy Kennedy
1Oxford GlycoSciences (UK), The Forum, 86 Milton Park, Abingdon, UK OX14 4RY. lan.bandara@ogs.co.uk
Drug Discovery Today
|March 28, 2002
Summary
The human genome provides vast genetic information for drug discovery and personalized medicine. Proteomics, the study of proteins, is increasingly vital for understanding toxicity and developing new toxicological approaches.
Area of Science:
- Genomics and Proteomics
- Toxicology
- Drug Discovery
Background:
- The human genome project has generated a wealth of genetic data.
- Genetic information has the potential to revolutionize drug discovery.
- Understanding protein function is key, highlighting the importance of proteomics.
Purpose of the Study:
- To discuss the applications of proteomics in toxicology.
- To explore how genomic and proteomic techniques can address toxicity issues.
Main Methods:
- Review of current literature on proteomics applications in toxicology.
- Analysis of the integration of genomic and proteomic data.
Main Results:
- Proteomics offers novel approaches for identifying drug targets and disease markers.
- Proteomic techniques can aid in the development of personalized medicines.
- The field of proteomics is crucial for understanding the link between genetic changes and protein function.
Conclusions:
- Proteomics is becoming increasingly important in the field of toxicology.
- Future toxicological research will likely integrate genomic and proteomic techniques.
- These integrated approaches promise to enhance our understanding and management of toxicity.